retatrutide phase 2 trial type 2 diabetes Reta clinical data & dosing โ a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in 3 trials for metabolic health โ targeting GLP-1, GIP ๐คAdults with type 2 diabetes
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 1 - Aug 6









/assets/images/provider/photos/2775923.jpeg)
















